Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 0 |
Since 2006 (last 20 years) | 2 |
Descriptor
Adolescents | 2 |
Autism | 2 |
Comparative Analysis | 2 |
Anxiety | 1 |
Attention Deficit Disorders | 1 |
Attention Span | 1 |
Behavior Problems | 1 |
Check Lists | 1 |
Children | 1 |
Control Groups | 1 |
Depression (Psychology) | 1 |
More ▼ |
Author
Aidikoff, Jenna M. | 1 |
Aman, Michael G. | 1 |
Arnold, L. Eugene | 1 |
Capone, George T. | 1 |
Cook, Amelia M. | 1 |
Goyal, Parag | 1 |
Hall, Kristy L. | 1 |
Ramadan, Yaser | 1 |
Thompson, Susan | 1 |
Witwer, Andrea N. | 1 |
Publication Type
Journal Articles | 2 |
Reports - Evaluative | 1 |
Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
Aberrant Behavior Checklist | 2 |
What Works Clearinghouse Rating
Capone, George T.; Aidikoff, Jenna M.; Goyal, Parag – Journal of Mental Health Research in Intellectual Disabilities, 2011
Caretakers of adolescents and young adults with Down syndrome (DS) may report the onset of a depressive illness in previously mentally well individuals. However, the behavioral phenomenology of these conditions has not been well characterized. We ascertained a cohort of DS patient-subjects presenting to a specialty clinic with medical and/or…
Descriptors: Anxiety, Attention Span, Autism, Withdrawal (Psychology)
Atomoxetine for Hyperactivity in Autism Spectrum Disorders: Placebo-Controlled Crossover Pilot Trial
Arnold, L. Eugene; Aman, Michael G.; Cook, Amelia M.; Witwer, Andrea N.; Hall, Kristy L.; Thompson, Susan; Ramadan, Yaser – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To explore placebo-controlled efficacy and safety of atomoxetine (ATX) for attention-deficit/hyperactivity disorder (ADHD) symptoms in children with autism spectrum disorders (ASD). Method: Children ages 5 to 15 with ASD and prominent ADHD symptoms were randomly assigned to order in a crossover of clinically titrated ATX and placebo, 6…
Descriptors: Hyperactivity, Autism, Drug Therapy, Attention Deficit Disorders